In the plasma of several cancer patients, specific mutations including TP53 mutations in blood samples from patients with small cell lung cancer (SCLC), KRAS mutations reported in tests of NSCLC patients, and BRCA1 mutations in blood samples from patients with breast cancer were detected by Pessoa et al. (Pessoa et al., 2020). The gene discussed is KRAS; the disease is small cell lung carcinoma.